Cyprus: Leader in Treatment of Beta-Thalassemia and Myelodysplastic Syndromes
Bristol Myers Squibb held a specialist conference in Cyprus on September 23, 2026, where current challenges, the importance of institutional collaboration, and new therapeutic options in the treatment of beta-thalassemia and myelodysplastic syndromes were discussed. Representatives from hematology and academic sectors participated in the event.